arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

download Export Data

INTELLIGENT BIO SOLUTIONS INC.

INBS

$1.80 ▼ -0.03 (-1.64%) at close

28 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

INTELLIGENT BIO SOLUTIONS INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth 35.8% ↗

Op. Margin -346.4% ↘

ROIC -56.9% ↘

FCF / Share None

Trailing P/E —

Price / Book 1.0x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

28-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.15M

↑ +35.8% —

Net Income Profit after all expenses

$-3.91M

↓ -26.5% —

Operating Margin Operating profit as % of sales

-346.4%

↓ -24.7% 0th

FCF / Share Free cash flow per share

$-2.72

↓ -58.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗
Revenue Growth YoY (%)	35.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+347%)	17.6% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+120%)	21.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+163%)	11.4% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+42%)	15.9% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+99%)	9.5% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+19%)	-3.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-138%)	25.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+218%)	64.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+703%)	80.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+903%)	114.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1328%)	155.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1846%)	—	137.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1618%)	100.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1158%)	—	—	461.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5667%)	-37.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-565%)	—	2230.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+27776%)	N/M	N/M	—	—	—	—	—
EPS Growth YoY (%)	78.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-309.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-464.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	50.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	69.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	75.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	32.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	75.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-350.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-1200.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-722.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-6255.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	-6875.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-26.5% Weak ↓ Weak Declining Year-over-year change in net income	-12.5% Weak ↑ Weak Improving Year-over-year change in net income	-19.0% Weak ↓ Weak Declining Year-over-year change in net income	-11.1% Weak ↓ Weak Declining Year-over-year change in net income	-11.0% Weak ↓ Weak Declining Year-over-year change in net income	14.6% Fair ↑ Fair Improving Year-over-year change in net income	-14.2% Weak ↓ Weak Declining Year-over-year change in net income	-10.7% Weak ↑ Weak Improving Year-over-year change in net income	-4.7% Weak ↑ Weak Improving Year-over-year change in net income	53.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-368.3% Weak ↓ Weak Declining Year-over-year change in net income	-100.7% Weak → Weak Stable Year-over-year change in net income	-27.9% Weak ↑ Weak Improving Year-over-year change in net income	-375.1% Weak ↓ Weak Declining Year-over-year change in net income	87.8% Excellent ↑ Excellent Improving Year-over-year change in net income	15.7% Good ↑ Good Improving Year-over-year change in net income	-143.6% Weak ↓ Weak Declining Year-over-year change in net income	57.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-74.4% Weak ↑ Weak Improving Year-over-year change in net income	-33.6% Weak ↑ Weak Improving Year-over-year change in net income	-86.6% Weak ↑ Weak Improving Year-over-year change in net income	-2678.0% Weak Weak Year-over-year change in net income	-8.0% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	—	—	45.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-11.3% Weak Weak Year-over-year change in free cash flow	—	—	—	-342.6% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	37.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	32.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	36.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	52.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	—	67.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	60.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	—	-23.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	188.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	39.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	143.1% Excellent Excellent Compound annual revenue growth over 3 years	85.9% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-6.6% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	98.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	25.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	82.2% Excellent Excellent Compound annual revenue growth over 5 years	65.0% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗
Operating Margin (%) (%)	-346.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2409%)	-277.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1952%)	-293.9% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2059%)	-269.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1899%)	-368.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2554%)	-283.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1987%)	-305.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2137%)	-273.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1920%)	-386.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2675%)	-358.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2490%)	-260.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1838%)	-317.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2216%)	—	—	—	-391.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2709%)	—	—	—	—	-53.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-454%)	—	-324.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2261%)	—	—	—	—	—
Profit Margin (%) (%)	-341.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2942%)	-269.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2349%)	-298.6% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2588%)	-268.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2336%)	-366.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3151%)	-281.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2450%)	-303.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2629%)	-269.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2342%)	-382.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3288%)	-361.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3112%)	-257.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2248%)	-304.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2639%)	—	—	-117.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1083%)	-388.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3334%)	—	—	—	—	-53.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-542%)	—	—	—	—	—	—	—
FCF Margin (%) (%)	-277.7% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	-409.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-182.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-262.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-261.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-239.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-404.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-164.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-131.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	-104.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	282.6% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.52x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.06x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.54x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.22x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.57x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	-0.06x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.97x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	2.50x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.43x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.94x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗
Return on Invested Capital (%)	-56.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-65.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-81.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-39.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-22.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-48.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-147.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-56.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-85.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-27.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	7.8% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-33.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-37.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-61.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-20.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-70.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-573%)	-31.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-313%)	-24.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-261%)	-82.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-649%)	-103.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-788%)	-49.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-432%)	-51.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-443%)	-44.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-393%)	-33.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-323%)	-26.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-278%)	-60.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-500%)	-178.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1293%)	-70.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-567%)	-105.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-802%)	-4.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-127%)	-22.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-253%)	-31.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-309%)	-15.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-201%)	-34.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-328%)	-10.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-5.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-138%)	-19.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-231%)	-10.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	—	8.8% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-41%)	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	0.20x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-67%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-7.79x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.55x Weak Weak Operating income divided by interest expense Optimal: > 5x	-0.36x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-3.99M	$-6.86M	$-740.37K	$-1.66M	$-1.02M	$-2.81M	$-2.24M	$-3.99M	$-4.65M	$-9.40M	$-1.12M	$-186.40K	$-1.54M	$-2.28M	$-2.91M	$-5.74M	$-8.24M	$-10.76M	$-11.19M	$-12.61M	$-12.57M	$-14.26M	$-19.88M	—	$-427.27K	—	—	—
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	-0.64x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗
Revenue per Share (USD)	—	$0.67	$0.94	$0.13	—	$0.16	$0.16	$0.26	—	$0.40	$0.80	$0.34	—	$0.41	$0.39	$0.02	—	$0.01	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.90	$-1.80	$-2.82	$-0.35	$-4.12	$-0.44	$-0.50	$-0.70	$0.26	$-1.43	$-2.07	$-1.04	$-22.96	$-5.72	$-0.46	$-0.08	$-2.79	$-0.09	—	—	$-0.04	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	—	$-2.72	$-1.72	$-0.34	—	—	—	$-0.63	—	—	—	$-0.56	—	—	—	$-0.13	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$1.90	$4.48	$8.96	$0.40	$4.09	$0.75	$0.91	$1.39	$2.41	$3.82	$2.22	$0.58	$19.56	$3.58	$11.28	$0.35	—	$0.59	$0.68	$0.91	$1.11	$1.34	$1.81	—	$-0.60	—	—	—
Tangible Book Value per Share (USD)	$0.93	$2.98	$6.32	$0.02	$-1.08	$0.19	$0.10	$0.39	$1.15	$2.24	$-1.07	$-1.51	$-7.50	$0.43	$0.82	$0.35	—	$0.59	$0.68	$0.91	$1.11	$1.34	$1.81	—	$-0.60	—	—	—
Basic Weighted Avg Shares (shares)	—	1.59M	950,829	8.55M	—	5.77M	4.54M	3.81M	—	2.08M	949,660	2.33M	—	1.11M	908,283	14.89M	—	14.89M	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗
Working Capital (USD)	$2.17M	$5.14M	$7.05M	$-577.71K	$-1.21M	$542.95K	$-341.24K	$800.11K	$3.08M	$5.81M	$-2.24M	$-4.15M	$-2.02M	$887.14K	$1.56M	$5.85M	$6.20M	$8.43M	$10.08M	$13.03M	$14.52M	$15.03M	$18.80M	—	$-5.35M	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	$1.65M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$5.51M	$8.96M	$11.09M	$3.62M	$3.00M	$5.11M	$4.37M	$6.10M	$8.33M	$11.13M	$3.28M	$1.36M	$3.80M	$6.03M	$10.35M	$5.28M	$6.62M	$8.77M	$10.11M	$13.56M	$15.06M	$15.93M	$18.82M	—	$-5.19M	—	—	$-3.98M

📋 What is driving earnings? 4 metrics

Metric	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$1.15M	$1.06M	$896.77K	$1.11M	$843.88K	$902.14K	$741.13K	$998.41K	$727.82K	$823.80K	$764.06K	$796.09K	$443.13K	$457.06K	$356.68K	$311.32K	—	$192.50K	$177.79K	—	$1.61M	$34.29K	$283.04K	$55.43K	$69.00K	$-1.53K	$-798.00	—
Depreciation Expense (USD)	—	—	$327.37K	$257.91K	—	$115.46K	—	$241.62K	$227.85K	—	—	$247.60K	$111.99K	$6.41K	—	—	$0.00	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-3.91M	$-2.86M	$-2.68M	$-2.98M	$-3.09M	$-2.54M	$-2.25M	$-2.69M	$-2.78M	$-2.98M	$-1.97M	$-2.43M	$-2.66M	$-6.34M	$-420.60K	$-1.21M	$-2.08M	$-1.34M	$-3.46M	$-1.43M	$-853.00K	$-3.13M	$-1.98M	$-1.07M	$-457.02K	$-112.59K	$-1.84M	—
Operating Cash Flow (USD)	$-3.18M	$-4.33M	$-1.57M	$-2.85M	$-2.21M	—	—	$-2.39M	$-2.94M	—	—	$-1.31M	$-584.34K	—	—	$-1.89M	$-1.72M	—	—	$82.96K	$-1.68M	—	—	$-2.68M	$194.97K	$-218.65K	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 8 years · 28 quarters

INTELLIGENT BIO SOLUTIONS INC.

Analytical Summary

28-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare INBS with peers